The Controlled Substance Utilization Review and Evaluation System (CURES) fee will increase from $9 to $15 annually for licenses expiring on and after July 1, 2025. The fee is assessed at the time of license renewal on licensees that are authorized to prescribe, order, administer, or furnish Schedule II, Schedule III, Schedule IV, or Schedule V controlled substances.

Most licensees will see a $30 CURES fee due to the biennial renewal cycle. The fee covers the reasonable regulatory costs of the Department of Justice for operating and maintaining CURES, a critical element in the state’s continued effort to address the danger of opioid addiction stemming from prescription drug abuse.

For more information about CURES, visit: https://oag.ca.gov/cures.

The Board of Registered Nursing (Board) will no longer require public health nurse certificates to be renewed. Passage of Assembly Bill 2471 (Patterson, Chapter 717, Statutes of 2024) removed both the renewal requirement and associated fee for public health nurse certificates.

A licensee’s public health nurse certificate will remain valid as long as their registered nurse license remains active. Please note that licensees must still apply and pay a fee to renew their registered nursing license as well as any advanced practice registered nurse certificates they may hold.

Monitor the Board’s website, www.rn.ca.gov, for more information as it becomes available.

Beginning January 1, 2025, nurse practitioners who provides primary care to a patient population of which over 25% are 65 years of age or older must complete at least 6 of the 30 continuing education hours required to renew their registered nurse license, in a course in the field of gerontology, the special care needs of patients with dementia, or the care of older patients.

Compliance with these new requirements will be verified as part of the NP certificate renewal process.

Monitor the Board’s website, Continuing Education for License Renewal, for more information.

As of August 1, 2024, all California dispensers of controlled substances are required to report dispensations to the Controlled Substance Utilization Review and Evaluation System (CURES) using the American Society of Automation in Pharmacy (ASAP) version 4.2B format. Please visit the Office of the Attorney General's CURES Website for information on this required change.

For information about CURES, visit DCA’s CURES information page.

SB 372, 2023 - Effective January 1, 2024, under Business and Professions Code section 27.5, licensees may notify the licensing board or bureau within the Department of Consumer Affairs (DCA) of a name and/or gender change and request confidentiality of the previous name or gender information, when meeting certain specified requirements. For more information and to make a request, click here.

The Department of Consumer Affairs (DCA) has learned of an attempted scam aimed at licensees of DCA’s boards and bureaus. In the scheme, an individual falsely identifying themselves as an employee of the Acupuncture Board has contacted licensees and attempted to gather personal information.

If you receive a call from an individual claiming to be an employee of the Acupuncture Board (or any other DCA board or bureau) and they attempt to gather personal information, please consider the following:

· If you receive a call, simply take down the caller’s information (including name, title, phone number and email address), let them know you will follow-up directly with the department/board/bureau, and end the call.
· You may also consider ending the call without explanation if it appears suspicious or to be a scam.
· Contact the board or bureau responsible for issuing your license. Contact information for all DCA boards and bureaus can be found via this webpage: https://www.dca.ca.gov/about_us/entities.shtml
· If you don’t know who to contact at DCA, call the Consumer Information Center at (800) 952-5210 for assistance and to get directed to the appropriate entity.
· NEVER disclose any personal information, i.e. social security numbers, date of births, or credit/debit card numbers, without first taking steps to verify that the person requesting the information has a legitimate need for it.

The California Board of Registered Nursing (BRN or Board) has learned that scam artists posing as U.S. Drug Enforcement Administration (DEA) agents or Board investigators are calling California registered nurses as part of an extortion scheme. The scammers identify themselves as DEA agents or Board investigators, calling about ongoing investigations regarding their license issued by the BRN. The scammers tell victims their license may be suspended for illegal drug trafficking. The scammers may provide a “Notice of Suspension” letter with BRN’s letterhead and/or logo which includes statements that licensees must follow instructions given by the Board investigator. The scammers are also asking for licensee bank account information. The scammers’ phone number may show up as the BRN’s office number (916) 322-3350.

No DEA agent, BRN investigator or staff member will ever contact RNs by telephone to demand money or any other form of payment. If you receive a call such as the one described, refuse the demand for payment. Do not disclose any personal information, i.e., social security number, dates of birth, credit or debit card numbers.

Please also consider the following:

• If the caller is stating they are from the DEA, immediately report the threat to the FBI's Internet Crime Complaint Center.
• If the individual identifies themselves as a Board employee, please contact the Board at (916) 322-3350 and press 3 to be directed to the Board’s Enforcement unit or send an email to Enforcement.BRN@dca.ca.gov.
• If the phone number of the caller appears to be the Board’s number, it is recommended that you submit an online complaint with the Federal Communications Commission (FCC) using the FCC's Consumer Complaint form or contact the Board so it can provide this information to the FCC.
• DEA Warns Public of Extortion Scam by DEA Special Agent Impersonators